Cargando…
Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment
Adoptive T-cell immunotherapies, including chimeric antigen receptor-modified T-cells (CAR-T cells), have revolutionized cancer treatment, especially for hematologic malignancies. Clinical success of CAR-T cell monotherapy in solid tumors however, has been only modest. Oncolytic viruses provide dire...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160535/ https://www.ncbi.nlm.nih.gov/pubmed/30298067 http://dx.doi.org/10.3389/fimmu.2018.02103 |